Despite the selloff, some analysts see long-term value. CLSA recently upgraded the stock to high conviction outperform,' citing attractive valuations and the potential for a cyclical recovery, setting a target price of Rs 930. However, BNP Paribas maintained an outperform' rating but warned of near-term uncertainties that could keep the stock under pressure in 2025.